BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11379831)

  • 1. Interpretations and conclusions in the clinical trial.
    Docherty JP
    J Clin Psychiatry; 2001; 62 Suppl 9():40-3; discussion 44-5. PubMed ID: 11379831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The statistical comparison of clinical trials.
    Schooler NR
    J Clin Psychiatry; 2001; 62 Suppl 9():35-7; discussion 38-9. PubMed ID: 11379830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction: evaluating clinical trial data from schizophrenia research.
    Tamminga CA
    J Clin Psychiatry; 2001; 62 Suppl 9():3-4. PubMed ID: 11379829
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical development of atypical antipsychotics: research design and evaluation. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():10-6. PubMed ID: 9766614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating characteristics of patient selection and dropout rates.
    Keith SJ
    J Clin Psychiatry; 2001; 62 Suppl 9():11-4; discussion 15-6. PubMed ID: 11379825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrete state analysis for interpretation of data from clinical trials.
    Sugar CA; James GM; Lenert LA; Rosenheck RA
    Med Care; 2004 Feb; 42(2):183-96. PubMed ID: 14734956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.
    Nasrallah HA
    J Clin Psychiatry; 2007; 68 Suppl 1():5-11. PubMed ID: 17286522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research.
    Galgut PN
    J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CATIE schizophrenia trial: results, impact, controversy.
    Manschreck TC; Boshes RA
    Harv Rev Psychiatry; 2007; 15(5):245-58. PubMed ID: 17924259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and interpretation of data obtained from clinical trials in pain management.
    Theodore BR; Gatchel RJ
    Pain Pract; 2008; 8(6):461-72. PubMed ID: 19000174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is next in ALS clinical trials?
    Sorenson EJ
    Neurology; 2007 Aug; 69(8):719-20. PubMed ID: 17709702
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing the validity of clinical trials.
    Akobeng AK
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative analysis of how advanced practice nurses use clinical decision support systems.
    Weber S
    J Am Acad Nurse Pract; 2007 Dec; 19(12):652-67. PubMed ID: 18042131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new 'mechanistic-practical" framework for designing and interpreting randomized trials.
    Karanicolas PJ; Montori VM; Devereaux PJ; Schünemann H; Guyatt GH
    J Clin Epidemiol; 2009 May; 62(5):479-84. PubMed ID: 18468856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting and interpreting results of systematic reviews.
    Harvey L; Wyndaele JJ
    Spinal Cord; 2009 Nov; 47(11):777. PubMed ID: 19890366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.